One week left to book your exhibit table at TechCrunch Disrupt 2026
Only one week left to secure your exhibit table. Tables are limited and can sell out before the September 18 deadline.
ai
Final, final, final call for TechCrunch Disrupt 2026 Side Events
The absolute last chance to apply to host an official Side Event during TechCrunch Disrupt 2026 is tonight, September 11, at 11:59 p.m. PT.
Kimi-maker Moonshot AI targets $2B in annual revenue
While K3’s usage figures have declined slightly in recent months, OpenRouter data currently shows as many as 300 billion tokens being generated each day by K3 models on the system.
Roblox is making it easier to build games with AI — and play them outside Roblox
At its annual Roblox Developer Conference (RDC), the company announced several new features, including new game-creation tools, expanded NPC capabilities, and the ability to make games available across platforms, including the web.
Anthropic Says Russian Hackers Used Claude AI to Automate Malware Evasion
Anthropic reveals how criminal groups are increasingly targeting AI vendors’ own infrastructure, including to steal a pre-release Claude model. The post Anthropic Says Russian Hackers Used Claude AI to Automate Malware Evasion appeared first on SecurityWeek.
OpenAI’s Fidji Simo to Join Board of Cloud Provider Nscale Ahead of IPO
Former OpenAI executive Fidji Simo has joined the board of directors at Nscale, a startup that has raised billions to build data centers for AI.
The Special Forces Ethos Driving Goruck’s Co-Founders
Ipsen Weighs U.S. Manufacturing Investment
The French drugmaker is considering building a U.S. production site, joining other European companies looking across the pond when planning new investments.
Congress Is Suddenly Waking Up to the AI Doomsday Threat
After years of limited action, dozens of lawmakers on both sides of the aisle are touting new proposals to regulate artificial-intelligence models.
The Race for the Next Big Weight-Loss Drug Is On—and China Wants In
Long a maker of low-end generic drugs, the country is now home to biotech firms that are innovating fast.